We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+13.01%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$46.3M
AUM Growth
-$7.06M
Cap. Flow
-$13.8M
Cap. Flow %
-29.76%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
EGHT icon
8x8 Inc
EGHT
+$553

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$11.9M
2
SANA icon
Sana Biotechnology
SANA
+$1.83M

Sector Composition

Rank Sector Weight
1 Healthcare 96.44%
2 Technology 3.56%

No holdings matched the selected filter criteria.

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q1 2026 Portfolio in Review

As of Q1 2026, Crestline Management held 3 positions worth $46.3M, down 13% from $53.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Crestline Management withdrew a net $13.8M in Q1 2026, reducing 2 holdings. Its largest reduction was Denali Therapeutics, cutting an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Technology.

Against the trend, Crestline Management added an estimated $553 to 8x8 Inc.

  • Crestline Management added most to 8x8 Inc in Q1 2026, an estimated $553 increase.
  • Crestline Management's biggest Q1 2026 reduction was Denali Therapeutics, cutting an estimated $11.9M.
  • Crestline Management's ten largest holdings make up 100% of its $46.3M portfolio in Q1 2026.
  • Crestline Management opened 0 new positions and closed 0 in Q1 2026.
  • Crestline Management's portfolio value fell 13% quarter-over-quarter to $46.3M.

Based on Crestline Management's 13F filing for Q1 2026, filed 15 May 2026.